According to the present analysis of Reports and Data, the global central venous catheters market size is predicted to surpass USD 2.38 billion million by the year 2027, growing at a CAGR of seven .1%. Catheters emerged as an efficient medication delivery mechanism for surgical procedures and to treat other diseases. Central venous catheters are medical devices, used for the treatment of varied cardiovascular and other chronic disorders. A catheter is inserted within the arm or chest into a major vein. It penetrates the internal jugular vein, subclavian vein, or femoral vein to reach a larger vain to administer medicines, fluids, blood, nutrients, and blood products. Also, these catheters are designed to measure Central blood pressure (CVP), hemodialysis, and chemotherapy levels over an extended period of time.
Major factors propelling the expansion of central venous catheters market are the increase in geriatric population, vulnerable to different cardiovascular diseases, government initiatives & grants and therefore the increase in private investment in R&D activities. Manufacturers within the central venous catheters market are expanding their strategic business activities through merger and acquisitions to reinforce their product portfolio and expand customer base, which inspires the expansion of the target market. For instance, in November 2018, CVS Health and Aetna formed a merger to make an innovative health and activity solutions company. The corporate focused on strengthening its foothold within the near future.
Central Venous Catheters Market: Regional Outlook
North America held a dominant position within the global central venous catheters market owing to technological advancements, large patient pool, and awareness about advanced treatments within the region. The region is predicted to continue its lead over the forecast period. Moreover, the increase in healthcare expenditure, availability of approved medical devices, and increasing investments are key factors that are anticipated to spice up the central venous catheters market within the next few years.
The Asia Pacific central venous catheters market is projected to register a commendable CAGR thanks to increasing awareness regarding medical devices in developing countries and rising research initiatives in countries like Japan and China. As per the World Health Organization, Singapore holds the sixth rank within the world for its advanced healthcare system and offers the fourth best healthcare infrastructure across the planet. Demand for advanced medical technologies is anticipated to strengthen the country’s reputation as a healthcare hub within the region.
Central Venous Catheters Market: Key Players
• Edwards Life sciences,
• Angio Dynamics
• C.R.Bard
• Lepu Medical Technology
• Kimal, Terumo Corporation
• Vygon (U.K.) Ltd
• Becton Dickinson Company
• Medrad (Bayer AG)
• Johnson and Johnson
• Rochester Medical Co
Impact of COVID19 On Central Venous Catheters Market:
The COVID-19 pandemic has brought the planet to a temporary halt and because the number of infections and death still rise, all nations are fervently hoping to develop a vaccine which will bring this virus in check . But within the meantime, the healthcare industry is extremely over-burdened trying to possess to affect the coronavirus crisis on one hand and ardently trying to develop a vaccine which will grant a minimum of temporary immunity against the virus. The demographic most in danger of contracting the coronavirus are the elderly and patients with pre-existing conditions. It’s been noted the patients with comorbidities are likelier to succumb to the virus instead of healthy individuals. Patients who become dangerously ill due to the attack of coronavirus are often needing to be put in ICUs. It had been found that almost 25% of all coronavirus patients ended up in ICUs and needed mechanical ventilation. Many of those patients also needed the insertion of central venous catheters for the administration of nutrition and drugs. Till the time a vaccine is developed for coronavirus and even after it’s developed, while people become severely ill due to the virus, the central venous catheters will register substantial growth because the equipment becomes a crucial part keep patients alive.
Report Highlights:
- Detailed overview of the market
- Evolving central venous catheters market dynamics
- In-depth central venous catheters market classification
- Historical, present, and anticipated central venous catheters market size and share in terms of volume and value
- Recent central venous catheters market trends and advances
- Competitive landscape
- Strategies adopted by key players and products portfolio
- Segments, sub-segments, and geographic regions exhibiting growth prospects
- A neutral and global perspective on central venous catheters market performance
Central Venous Catheters Market: Segmentation
For the purpose of this study, Reports and Data have segmented the Central Venous Catheters market into product types, property type, design type, composition type, sales channel type, End user type, and region.
By Product (Revenue, USD Million; 2017-2027)
- Tunneled Catheters
- Non-Tunneled Catheters
By Property (Revenue, USD Million; 2017-2027)
- Antimicrobial Catheters
- Non-Antimicrobial Catheters
By Design (Revenue, USD Million; 2017-2027)
- Single Lumen
- Double Lumen
- Multiple Lumen
By Composition (Revenue, USD Million; 2017-2027)
- Polyurethane
- Polycarbonate
- Silicon
By sales channel (Revenue, USD Million; 2017-2027)
- Direct sales
- Channel Sales
By End-User (Revenue, USD Million; 2017-2027)
- Hospital
- Ambulatory Surgical Centers
- Clinics
- Others
Regional Outlook (Revenue, USD Million; 2017-2027)
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- Latin America
